HRD

About

Biomarker type: Homologous recombination

Status: Deficient

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (2) HRD Ovarian Epithelial Tumor Bevacizumab, Olaparib
FDA (2) HRD High-Grade Serous Fallopian Tube Cancer Bevacizumab, Olaparib
FDA (2) HRD Peritoneal Serous Carcinoma Bevacizumab, Olaparib